What's New at CBER Update

You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).

This page has been updated recently.

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies
Posted: 7/18/2013

2013 Biological License Application Approvals
Updated: 7/18/2013

2013 Biological License Application Supplement Approvals
Updated: 7/18/2013

2013 Biological Device Application Approvals
Updated: 7/18/2013

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420